{"ticker": {"uuid": "e3c6982e-ae5c-4ff3-adc6-34eca37512f0", "symbol": "GIS", "name": "Gilead Sciences, Inc.", "exchange": "GER", "country": "DE", "sector": "Healthcare", "industry": "Drug Manufacturers - General"}, "articles": [{"title": "Gilead (GILD) CFO exercises 2,796 RSUs and withholds 1,341 shares for taxes", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQLVZ1Q3YtcGstaTl4bW9HWi1YV01OcEZHNkhPNXdteTBFNFVuanRXYkdZR05xM3lfMnhLMVFXTWVmb2ZvSzMzb1BwVkF6R20zSkpScTFLaERHVWtTanBtLTJIenV5ZHZRQVpxVUpvaGtZbTQ2Mi1sY3drS1lxcFBJa0Y1Z0tJSlFtcGxuS3VqN0pLMGNSQmJuYm1yOFpvdEFNNjIta3FySWI2bG1vTDBmU20xWQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T22:32:47+00:00", "published_display": "11 Jun 2026 22:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead (GILD) CMO Dietmar Berger converts RSUs and withholds shares for taxes", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNc2o3MHBpYnhIRTVVQVMwYUdnOFczQ2FvNFc4U3JOY3RBaWVidC0xTWZNdEhQdVdpWWs3ZjMxMTFRR0huTVVDMFlxRlpiY01PRG5zLUpENjllQnRFMGlmQnV0S0VCc0VhMWhVNWd0MVp2S29WT0NsamNzUE9jdnFjMmoxcFFaRk1PcklPeDNyT2JtSnFhWVZlY18teHlISWVRTkpKa1NoaEtsNmZYSVBjMmtoYw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead (GILD) CEO Daniel O'Day exercises RSUs and withholds shares for taxes", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOenNrSEh5QngyaTBINjhVdVV4VU5hTzZpMGZPeVBONlA5eTJZRjJtRUlYWk1iUlY2bFVHbFBZbXNLWDFlSEFjQmV1UlJydzlQN0VLcGk2aXV5YnlUSU9id0dTdmNHRHBfOWE0XzVGT0h6QlFpa2VrS29pZkYzVENDeXpVYmhTaDltQUY1dmpSWGtrekJpcS1oTFVMZHQxSWMxWGlEM2dOUTAzdno0dm1xY1BEWQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead (NASDAQ: GILD) officer reports RSU vesting and tax withholding on Form 4", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPcU1XZkN1RFFVX0dkOVlDNlo3QU5sR1A1QUpyY1dCX0hsX0dMcll5YUNfZmVpZmRhTXRTR0padGN3bktRSFpWVnJtY1VybkVHZlVZRlpSLVZZSEpYZFhsQ2ttRDk4RGtaVlp5dEpDOElwUnNBUi01TXNKUFdzelZFU2Y3STZKYWNqcjNLU21kOHJEWHBhc0NSWnVhUHo4ZFRzbVNpdXQ0bVdISXRsUUtVUWc3cw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead (GILD) Wins FDA Approval for First HDV Treatment Hepcludex", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNNDQtUXd6LTlxc0g3bVh6b2YyQ2VnbkFZMDg3MmttWDZLaXk1aDhCaDhBc3Nlbzl1Q1JuWFJaSWx2dW90QURlRHFONnRWdHdzQnRvSGsxbFZtOG1fb0htTk5Md3hNaklrY1FvYlcxMEFiN3ZibXptT3VUYkRnNUo5YjF6X2FWOHppQzdtdXhYb1E4UkREM2NhSGxtSTd6U00?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences, Inc. (GILD) Stock Analysis: Evaluating a 21.90% Upside Potential for Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxOYy1oaHBTZjVyemtqSGI0bE9IRDhxaXN3REtVOXRqVUE0V1NWb0xBaDl5Qk42SWRTa2IwMWNleDROLWUxcHZqamQ0SEFYMWtrUzNVYVJ3bnZVd3ZPMk9lQjZWRXl2LXpuWGNKWE4yUEVYS3ZSRzJZckpENGczRTUzX2luSmNYMU9hNGxsc19CX2UyeUZuekFjckhnU3hibUhPWWotTU81YlBGN3d1SWRjdVFrZElnSnA5R1NmQThRZlVZd0hfWDgzOU12Sl9EWlljdUozN1QzSQ?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-05-18T16:39:20+00:00", "published_display": "18 May 2026 16:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead to Acquire Tubulis, Strengthing Oncology Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxORHlMZjg3OWRaS05CVGNOeFlBUlpMMmIzem1VeWtNVEpKZl9vUEozWHVMR2NRTzh0Z1JFQkFDLWIwaFRJc2d0eVFvMDhjSHpMTVdtNkNfcW9ZLVA3ODYxa0x4NXU4NWVZM1pBSXNiNndMWldFQW1mNlhra19kdmxaZ3JXeURJTDlYQ0ZmZkRQMEk5YmlkT1pXZg?oc=5", "source_name": "CHEManager", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Expands Oncology Pipeline With $5B Tubulis Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNekl4QnFXbUxjOWFCUXplcm1oWUszd0JkaDU2cGxNLWxZYmxGTE9jSzYtZWwyc2p3SVFWaWxnc0JaZ2pIZlgta2YzS3JNbnBUQUctOTNsUWZpOVByYkhEWE8wUWpBbHFRbWNzZEFwaERRcnU0Y2FCWnk1Zk1TY1lMb1VkeUJHN05vYWtJNGRaS0RRdU40UnFjbWZCc2xaeThGV0wyUGZodw?oc=5", "source_name": "Market source", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) to Acquire Tubulis for $5B to Strengthen Oncology Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPdmRqd0FqY3hOMVE5T0RJUHVaUDZyOEFCUmpyTUdTejIxU0lrUF9oV01yZkNkS3lxeDEtYVhRMzRNN1JoY1R4QzZ3dzFFUFA2czN4ajJ1RDVfVmVGTGxsSnpKT2RfRlgyeUZrUTRmR0NzSmR6T3djanVjQVhyRnNWSWczSWdNTFZvaWVjc0MtWDJWRGx2bWxlUlVPYjhHVnpxM08tS1ZieGM?oc=5", "source_name": "Market source", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead's Stock Price is Expected to Rise to $160\uff0cGilead\u2019s $5 Billion Tubulis Deal Could Reshape the Cancer Drug Market of America", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNYktKSmxGRjVHQk1iUW0tcXdHX1N2UmQ3clhIR1JsQk5DUUhIbm01a0lldmUybm0xSEVUQ3dYcVRMVnA1UUJfcERUQVN1U1NPUW52aU05b215TEEyUVl1Q1Z6bFYwVGVkekw0NW5QanhoeG9XLVF3MnF4NU9OaENrLXFFSWZqdkt0czVHb245UjlLRzhnSFF4enc3TkNWejg4cWttempqclU0V203MWxCZWlZTmwzOGRBX2FrTkswTHV2X1JjZHlqQ3BCb292UQ?oc=5", "source_name": "TradingKey", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Is Doubling Down On Acquisitions (NASDAQ:GILD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQTFlaTDlTUlRWcjZOZ0xqeUQwcXFWX2lRbTRwNF9ieHRNaTdNOEFhZ0xfZFY1d1AySlZSMWRFekxxcUNSY2Z1V19JREVnN0p1bnhfTzdzaEN5NlJMSTZMZXBqcnc4RjgzZUdFZlRxZ1lYcVlPeW8xakM2OXBMbGttR1QxcDFuUEl5a3JQeERucXAwUms?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead to Buy Cancer Biotech Tubulis in $5 Billion Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNUVlVb3FPNFFkSkFlb2puclNiRTZ3SDkwRDRTanVfNzA4alFzNlJLTEFCWWpJX1ZwYklSLW95ci1oUFFwSktOSndRdEVIUGJrZklldlVqN2kzb1hfRzFOQzZJVDR3X01qTXdzMUY0aXBEMXVuRVJLUExJaFY3Smw1TXkzUXk1ZUk5MHk0eFJyQ1JYM0JIc2ctOEpmN0JhbjdVVHF4Z0Q0NHNUbXNHcFNmcXNn?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOUGNSRm5Yc0IxZ0lvMDRibFcwdkh6U0pwbUZCWGpDSk0zcXljUUFjdXFkMVV0eXdaVTVxd1NPRFEwRl9JdlpEMFNzR29zREdSX0Q0Nm1PTGdfUnpKSmhGaS1GMlN2QUlIYkh3SXNOMHV6MldwdGlFUTdrdVJscDlDMW1FSGY1OVF2bk11LWlrR3VVLUZQVlc1dEFXUm0?oc=5", "source_name": "Reuters", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgJBVV95cUxNQkNGVzd2UmxqMXhLS1NERHdUUDBOdzFXaDFZMmNZZTZ0ZTFvVlFrY0twUTNkZXRKa3JNc1k4RnhlQVM4Y3FkN1JlOFhGZ2VtMUs5aVYxYXp5cjU2ckxRRjdqTzF6c1N6aWgtV2dlV25tempJLV9xT09uSGUwX0txWDVaTFVZWXFHUy05U0oxVFFsTDRoelhrVUNPUFBWeWhxT3FmM2F3Ylo0R21iTWZTdGFSeURxS1h3UXF4cWhjbW1rTERfUEpBbUJfMFd0Z0VGMWhrVnhxRHNWZVNCbTc3Uk91TlhDQ3plS0NpNmk4Qk9YaUozVXhkU1pMSjJyUWtwYzQ1ZlRsN0U0TjVkSGNwNWJUQ28xbTdfMXYtUmVyTnY2MENsRlJPcFFuSEZTWWRJWWc?oc=5", "source_name": "Business Wire", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead to acquire Tubulis GmbH for $5B (GILD:NASDAQ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPX1IwMFJXdHJRc0x5dkp2SWNFRU81dGp6aG1sdnV5S18zMkE3dWNKOVAyYWtzRmZuQzRDVldoOV8xRHppLUhfSmltLVVSeEhYVUdYcDQzR3JYV2prNVlFMGtBQWhVRTBVaVNVdE85blczQmo5czl4NlphdEhjTHV2cg?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead to acquire Tubulis GmbH for up to $5 billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPR1J4MVRHQ2hXaV9xSy1TN1o4RG10UHQwRmFDYWx6NDB2RzJOeXN0WHZ1TG9rVGhXMVo0Qm1RVnlxQjVVODgwZlYwamRPOTZQcHlORmVVOGRZbEhSckp3amNod1dGV1lDMS1Bd1VYR0FSV1hKaUtDUU13NkVfWTVZS0FzR1E?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Gilead (GILD) CFO exercises 2,796 RSUs and withholds 1,341 shares for taxes", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxQLVZ1Q3YtcGstaTl4bW9HWi1YV01OcEZHNkhPNXdteTBFNFVuanRXYkdZR05xM3lfMnhLMVFXTWVmb2ZvSzMzb1BwVkF6R20zSkpScTFLaERHVWtTanBtLTJIenV5ZHZRQVpxVUpvaGtZbTQ2Mi1sY3drS1lxcFBJa0Y1Z0tJSlFtcGxuS3VqN0pLMGNSQmJuYm1yOFpvdEFNNjIta3FySWI2bG1vTDBmU20xWQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T22:32:47+00:00", "published_display": "11 Jun 2026 22:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead (GILD) CMO Dietmar Berger converts RSUs and withholds shares for taxes", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxNc2o3MHBpYnhIRTVVQVMwYUdnOFczQ2FvNFc4U3JOY3RBaWVidC0xTWZNdEhQdVdpWWs3ZjMxMTFRR0huTVVDMFlxRlpiY01PRG5zLUpENjllQnRFMGlmQnV0S0VCc0VhMWhVNWd0MVp2S29WT0NsamNzUE9jdnFjMmoxcFFaRk1PcklPeDNyT2JtSnFhWVZlY18teHlISWVRTkpKa1NoaEtsNmZYSVBjMmtoYw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead (GILD) CEO Daniel O'Day exercises RSUs and withholds shares for taxes", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOenNrSEh5QngyaTBINjhVdVV4VU5hTzZpMGZPeVBONlA5eTJZRjJtRUlYWk1iUlY2bFVHbFBZbXNLWDFlSEFjQmV1UlJydzlQN0VLcGk2aXV5YnlUSU9id0dTdmNHRHBfOWE0XzVGT0h6QlFpa2VrS29pZkYzVENDeXpVYmhTaDltQUY1dmpSWGtrekJpcS1oTFVMZHQxSWMxWGlEM2dOUTAzdno0dm1xY1BEWQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead (NASDAQ: GILD) officer reports RSU vesting and tax withholding on Form 4", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPcU1XZkN1RFFVX0dkOVlDNlo3QU5sR1A1QUpyY1dCX0hsX0dMcll5YUNfZmVpZmRhTXRTR0padGN3bktRSFpWVnJtY1VybkVHZlVZRlpSLVZZSEpYZFhsQ2ttRDk4RGtaVlp5dEpDOElwUnNBUi01TXNKUFdzelZFU2Y3STZKYWNqcjNLU21kOHJEWHBhc0NSWnVhUHo4ZFRzbVNpdXQ0bVdISXRsUUtVUWc3cw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead (GILD) Wins FDA Approval for First HDV Treatment Hepcludex", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNNDQtUXd6LTlxc0g3bVh6b2YyQ2VnbkFZMDg3MmttWDZLaXk1aDhCaDhBc3Nlbzl1Q1JuWFJaSWx2dW90QURlRHFONnRWdHdzQnRvSGsxbFZtOG1fb0htTk5Md3hNaklrY1FvYlcxMEFiN3ZibXptT3VUYkRnNUo5YjF6X2FWOHppQzdtdXhYb1E4UkREM2NhSGxtSTd6U00?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences, Inc. (GILD) Stock Analysis: Evaluating a 21.90% Upside Potential for Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxOYy1oaHBTZjVyemtqSGI0bE9IRDhxaXN3REtVOXRqVUE0V1NWb0xBaDl5Qk42SWRTa2IwMWNleDROLWUxcHZqamQ0SEFYMWtrUzNVYVJ3bnZVd3ZPMk9lQjZWRXl2LXpuWGNKWE4yUEVYS3ZSRzJZckpENGczRTUzX2luSmNYMU9hNGxsc19CX2UyeUZuekFjckhnU3hibUhPWWotTU81YlBGN3d1SWRjdVFrZElnSnA5R1NmQThRZlVZd0hfWDgzOU12Sl9EWlljdUozN1QzSQ?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-05-18T16:39:20+00:00", "published_display": "18 May 2026 16:39", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead to Acquire Tubulis, Strengthing Oncology Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxORHlMZjg3OWRaS05CVGNOeFlBUlpMMmIzem1VeWtNVEpKZl9vUEozWHVMR2NRTzh0Z1JFQkFDLWIwaFRJc2d0eVFvMDhjSHpMTVdtNkNfcW9ZLVA3ODYxa0x4NXU4NWVZM1pBSXNiNndMWldFQW1mNlhra19kdmxaZ3JXeURJTDlYQ0ZmZkRQMEk5YmlkT1pXZg?oc=5", "source_name": "CHEManager", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Expands Oncology Pipeline With $5B Tubulis Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNekl4QnFXbUxjOWFCUXplcm1oWUszd0JkaDU2cGxNLWxZYmxGTE9jSzYtZWwyc2p3SVFWaWxnc0JaZ2pIZlgta2YzS3JNbnBUQUctOTNsUWZpOVByYkhEWE8wUWpBbHFRbWNzZEFwaERRcnU0Y2FCWnk1Zk1TY1lMb1VkeUJHN05vYWtJNGRaS0RRdU40UnFjbWZCc2xaeThGV0wyUGZodw?oc=5", "source_name": "Market source", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences (GILD) to Acquire Tubulis for $5B to Strengthen Oncology Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPdmRqd0FqY3hOMVE5T0RJUHVaUDZyOEFCUmpyTUdTejIxU0lrUF9oV01yZkNkS3lxeDEtYVhRMzRNN1JoY1R4QzZ3dzFFUFA2czN4ajJ1RDVfVmVGTGxsSnpKT2RfRlgyeUZrUTRmR0NzSmR6T3djanVjQVhyRnNWSWczSWdNTFZvaWVjc0MtWDJWRGx2bWxlUlVPYjhHVnpxM08tS1ZieGM?oc=5", "source_name": "Market source", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead's Stock Price is Expected to Rise to $160\uff0cGilead\u2019s $5 Billion Tubulis Deal Could Reshape the Cancer Drug Market of America", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxNYktKSmxGRjVHQk1iUW0tcXdHX1N2UmQ3clhIR1JsQk5DUUhIbm01a0lldmUybm0xSEVUQ3dYcVRMVnA1UUJfcERUQVN1U1NPUW52aU05b215TEEyUVl1Q1Z6bFYwVGVkekw0NW5QanhoeG9XLVF3MnF4NU9OaENrLXFFSWZqdkt0czVHb245UjlLRzhnSFF4enc3TkNWejg4cWttempqclU0V203MWxCZWlZTmwzOGRBX2FrTkswTHV2X1JjZHlqQ3BCb292UQ?oc=5", "source_name": "TradingKey", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead Sciences Is Doubling Down On Acquisitions (NASDAQ:GILD)", "summary": "", "url": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQTFlaTDlTUlRWcjZOZ0xqeUQwcXFWX2lRbTRwNF9ieHRNaTdNOEFhZ0xfZFY1d1AySlZSMWRFekxxcUNSY2Z1V19JREVnN0p1bnhfTzdzaEN5NlJMSTZMZXBqcnc4RjgzZUdFZlRxZ1lYcVlPeW8xakM2OXBMbGttR1QxcDFuUEl5a3JQeERucXAwUms?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead to Buy Cancer Biotech Tubulis in $5 Billion Deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNUVlVb3FPNFFkSkFlb2puclNiRTZ3SDkwRDRTanVfNzA4alFzNlJLTEFCWWpJX1ZwYklSLW95ci1oUFFwSktOSndRdEVIUGJrZklldlVqN2kzb1hfRzFOQzZJVDR3X01qTXdzMUY0aXBEMXVuRVJLUExJaFY3Smw1TXkzUXk1ZUk5MHk0eFJyQ1JYM0JIc2ctOEpmN0JhbjdVVHF4Z0Q0NHNUbXNHcFNmcXNn?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOUGNSRm5Yc0IxZ0lvMDRibFcwdkh6U0pwbUZCWGpDSk0zcXljUUFjdXFkMVV0eXdaVTVxd1NPRFEwRl9JdlpEMFNzR29zREdSX0Q0Nm1PTGdfUnpKSmhGaS1GMlN2QUlIYkh3SXNOMHV6MldwdGlFUTdrdVJscDlDMW1FSGY1OVF2bk11LWlrR3VVLUZQVlc1dEFXUm0?oc=5", "source_name": "Reuters", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgJBVV95cUxNQkNGVzd2UmxqMXhLS1NERHdUUDBOdzFXaDFZMmNZZTZ0ZTFvVlFrY0twUTNkZXRKa3JNc1k4RnhlQVM4Y3FkN1JlOFhGZ2VtMUs5aVYxYXp5cjU2ckxRRjdqTzF6c1N6aWgtV2dlV25tempJLV9xT09uSGUwX0txWDVaTFVZWXFHUy05U0oxVFFsTDRoelhrVUNPUFBWeWhxT3FmM2F3Ylo0R21iTWZTdGFSeURxS1h3UXF4cWhjbW1rTERfUEpBbUJfMFd0Z0VGMWhrVnhxRHNWZVNCbTc3Uk91TlhDQ3plS0NpNmk4Qk9YaUozVXhkU1pMSjJyUWtwYzQ1ZlRsN0U0TjVkSGNwNWJUQ28xbTdfMXYtUmVyTnY2MENsRlJPcFFuSEZTWWRJWWc?oc=5", "source_name": "Business Wire", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead to acquire Tubulis GmbH for $5B (GILD:NASDAQ)", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPX1IwMFJXdHJRc0x5dkp2SWNFRU81dGp6aG1sdnV5S18zMkE3dWNKOVAyYWtzRmZuQzRDVldoOV8xRHppLUhfSmltLVVSeEhYVUdYcDQzR3JYV2prNVlFMGtBQWhVRTBVaVNVdE85blczQmo5czl4NlphdEhjTHV2cg?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Gilead to acquire Tubulis GmbH for up to $5 billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAFBVV95cUxPR1J4MVRHQ2hXaV9xSy1TN1o4RG10UHQwRmFDYWx6NDB2RzJOeXN0WHZ1TG9rVGhXMVo0Qm1RVnlxQjVVODgwZlYwamRPOTZQcHlORmVVOGRZbEhSckp3amNod1dGV1lDMS1Bd1VYR0FSV1hKaUtDUU13NkVfWTVZS0FzR1E?oc=5", "source_name": "Yahoo! Finance Canada", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 90, "total_relevant": 16, "sentiment_summary": {"positive": 4, "negative": 0, "neutral": 12, "score": 55, "total": 16, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 6.75, "count": 11}, {"event": "deals", "label": "Deals and strategy", "weight": 2.9, "count": 4}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 4, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 108.02, "latest_week": "2026-06-19", "one_week_move": 1.1, "four_week_move": -5.1, "twelve_week_move": -8.0, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.888128, "market_dynamics_buy_signal": false, "relative_strength": -1.979244, "fair_value_gap": 29.0, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 55.3279, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+1.1% over one week, -5.1% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 65, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 4}, {"label": "Market source", "count": 3}, {"label": "Seeking Alpha", "count": 2}, {"label": "DirectorsTalk Interviews", "count": 1}, {"label": "CHEManager", "count": 1}, {"label": "TradingKey", "count": 1}, {"label": "Bloomberg.com", "count": 1}, {"label": "Reuters", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 16}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 11}, {"label": "Deals and strategy", "count": 4}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "16", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "4", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+1.1% over one week, -5.1% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Gilead (GILD) CFO exercises 2,796 RSUs and withholds 1,341 shares for taxes"}], "updated_at": "2026-06-22T09:41:13.886446+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}